$40 by nextMarch.

eln is a stock that US analyts still don't pay attention because it's foreign. Those people only care about BIIB, ELN's US partner. But the partnership is 50/50. So I like ELN.

Multiple sclerosis application is being waited now. But there are two more applications being applied. In addition there is a compound testing for Alzheimer's Disease.

Given some time, it can go back to the levels from 4-5 years ago.